Stem cells as therapy for cardiac disease - a review

Folia Histochemica et Cytobiologica

Volumn 49, Issue 1, 2011, Pages 13-25

  Jezierska Woźniak, Katarzyna ^a   Mystkowska, Dorota ^a   Tutas, Anna ^a   Jurkowski, Marek Kajetan ^b  

^a UNIVERSITY OF WARMIA AND MAZURY IN OLSZTYN   (Poland)

^b INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

Cell therapy; Heart failure; Paracrine signaling; Stem cells

Indexed keywords

ATAXIN 1; CELL PROTEIN; CYTOKINE; GROWTH FACTOR; PROTEIN ISL 1; STEM CELL FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ADIPOSE DERIVED STEM CELL; ADULT STEM CELL; CARDIAC STEM CELL; CARDIOSPHERE DERIVED PROGENITOR CELL; CELL DIFFERENTIATION; CELL FATE; CELL HOMING; CELL PROTECTION; CLINICAL TRIAL (TOPIC); DNA MODIFICATION; EMBRYONIC STEM CELL; ENDOTHELIAL PROGENITOR CELL; ENGRAFTMENT; HEART DEVELOPMENT; HEART DISEASE; HEART FUNCTION; HEART VENTRICLE TACHYCARDIA; HEMATOPOIETIC STEM CELL; HUMAN; INTRACORONARY INFUSION; ISCHEMIC CARDIOMYOPATHY; MESENCHYMAL STEM CELL; MYOBLAST; NONHUMAN; NUCLEAR REPROGRAMMING; PARACRINE SIGNALING; PLURIPOTENT STEM CELL; PROTEIN EXPRESSION; PROTEIN SECRETION; REVIEW; SIDE POPULATION CELL; STEM CELL; STEM CELL MOBILIZATION; STEM CELL TRANSPLANTATION; TISSUE REGENERATION;

ANIMALIA;

EID: 79958090394     PISSN: 02398508     EISSN: 18975631     Source Type: Journal    
DOI: 10.5603/FHC.2011.0004     Document Type: Review

References (172)

1. Keller G. Embryonic stem cell differentiation: emergence of a new era in biology and medicine. Genes Dev. 2005;19:1129-155.
2. Murry CE, Keller G. Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Cell. 2008;132:661-680.
3. Klug MG, Soonpaa MH, Koh GY, Field LJ. Genetically selected cardiomyocytes from differentiating embryonic stem cells from stable intracardiac grafts. J Clin Invest. 1996;98:216-224.
4. Kehat I, Khimovich L, Caspi O et al. Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat Biotechnol. 2004;22:1282-1289.
5. Behfar A, Zingman LV, Hodgson DM et al. Stem cell differentiation requires a paracrine pathway in the heart. The FASEB Journal. 2002;16:1558-1566.
6. Laflamme MA, Gold J, Xu C et al. Formation of human myocardium in the rat heart from human embryonic stem cells. Am J Pathol. 2005;167:663-671.
7. Yan P, Nagasawa A, Uosaki H et al. Cyclosporin-A potently induces highly cardiogenic progenitors from embryonic stem cells. Biochem Biophys Res Commun. 2009;379:115-120.
8. + embryonic-stem-cell-derived population. Nature. 2008;453:524-528.
9. Wu SM, Fujiwara Y, Cibulsky SM et al. Developmental origin of a bipotential myocardial and smooth muscle cell precursor in the mammalian heart. Cell. 2006;127:1137-1150.
10. Singla DK, Hacker TA, Ma L et al. Transplantation of embryonic stem cells into the infarcted mouse heart: formation of multiple cell types. J Mol Cell Cardiol. 2006;40:195-200.
11. Kolossov E, Bostani T, Roell W et al. Engraftment of engineered ES cell-derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium. J Exp Med. 2006;203:2315-2327.
12. Hodgson DM, Behfar A, Zingman LV et al. Stable benefit of embryonic stem cell therapy in myocardial infarction. Am J Physiol Heart Circ Physiol. 2004;287:H471-H479.
13. Menard C, Hagege AA, Agbulut O et al. Transplantation of cardiac-committed mouse embryonic stem cells to infarcted sheep myocardium: a preclinical study. Lancet. 2005;366:1005-1012.
14. Laflamme MA, Chen KY, Naumova AV et al. Cardiomyo-cytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Bio-technol. 2007;25:1015-1024.
15. van Laake LW, Passier R, Doevendans PA, Mummery CL. Human embryonic stem cell-derived cardiomyocytes and cardiac repair in rodents. Circ Res. 2008;102:1008-1010.
16. Bahadur G. Ethics of testicular stem cell medicine Hum. Re-prod. 2004;19:2702-2710.
17. de Wert G, Mummery C. Human embryonic stem cells: research, ethics and policy Hum Reprod.n 2003;18:672-682.
18. Nussbaum J, Minami E, Laflamme MA et al. Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response. FASEB J. 2007;21:1345-1357.
19. Liu Y P, Dovzhenko OV, Garthwaite MA et al. Maintenance of pluripotency in human embryonic stem cells stably over-expressing enhanced green fluorescent protein. Stem Cells Dev. 2004;13:636-645.
20. Behfar A, Perez-Terzic C, Faustino RS et al. Cardiopoietic programming of embryonic stem cells for tumor-free heart repair. J Exp Med. 2007;204:405-420.
21. Sarić T, Frenzel L P, Hescheler J. Immunological barriers to embryonic stem cell-derived therapies. Cells Tissues Organs. 2008;188:78-90.
22. Passier R, van Laake LW, Mummery CL. Stem-cell-based therapy and lessons from the heart. Nature. 2008;453:15.
23. Zhang M, Methot D, Poppa V, Fujio Y, Walsh K, Murry CE. Cardiomyocyte grafting for cardiac repair: graft cell death and antideath strategies. J Mol Cell Cardiol. 2001;33:907-921.
24. Behfar A, Terzic A. Cardioprotective repair through stem cell-based cardiopoiesis. J Appl Physiol. 2007;103:1438-1440.
25. Behfar A, Faustino RS, Arrell DK, Dzeja P P, Perez-Terzic C, Terzic A. Guided stem cell cardiopoiesis: discovery and translation. J Mol Cell Cardiol. 2008;45:523-529.
26. Behfar A, Perez-Terzic C, Faustino RS et al. Cardiopoietic programming of embryonic stem cells for tumor-free heart repair. J Exp Med. 2007;204:405-420.
27. Behfar A, Terzic A. Optimizing adult mesenchymal stem cells for heart repair [editorial]. J Mol Cell Cardiol. 2007;42:283-284.
28. Faustino RS, Behfar A, Perez-Terzic C, Terzic A. Genomic chart guiding embryonic stem cell cardiopoiesis. Genome Biol. 2008;9:R6.
29. Arrell DK, Niederländer NJ, Faustino RS, Behfar A, Terzic A. Cardioinductive network guiding stem cell differentiation revealed by proteomic cartography of TNF α-primed endo-dermal secretome. Stem Cells. 2008;26:387-400.
30. Perez-Terzic C, Faustino RS, Boorsma BJ et al. Stem cells transform into a cardiac phenotype with remodeling of the nuclear transport machinery. Nat Clin Pract Cardiovasc Med. 2007; 4:S68-S76.
31. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663.
32. Takahashi K, Tanabe K, Ohnuki M et al. Induction of pluripo-tent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131:861-872.
33. Wernig M, Meissner A, Foreman R et al. In vitro reprogram-ming of fibroblasts into a pluripotent ES-cell-like state. Nature. 2007;448:318-324.
34. Okita K, Ichisaka T, Yamanaka S. Generation of germ-line competent induced pluripotent stem cells. Nature. 2007; 448:313-317.
35. Yamanaka S. Strategies and new developments in the generation of patient-specific pluripotent stem cells. Cell Stem Cell. 2007;1:39-49.
36. Guan K, Nayernia K, Maier LS et al. Pluripotency of sper-matogonial stem cells from adult mouse testis. Nature. 2006;440:1199-1203.
37. Freund C, Davis R P, Gkatzis K, Ward-van Oostwaard D, Mummery CL. The first reported generation of human induced pluripotent stem cells (iPS cells) and iPS cellderived cardiomyocytes in the Netherlands. Neth Heart J. 2010;18:51-54.
38. Yu J, Vodyanik MA, Smuga-Otto K et al. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007;318:1917-1920.
39. Jaenisch R, Young R. Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell. 2008; 132:567-582.
40. Martinez-Fernandez A, Nelson TJ, Yamada S et al. iPS programmed without c-MYC yield proficient cardiogenesis for functional heart chimerism. Circ Res. 2009;105:648-656.
41. Mauritz C, Schwanke K, Reppel M et al. Generation of functional murine cardiac myocytes from induced pluripotent stem cells. Circulation. 2008;118:507-517.
42. Liu YH, Karra R, Wu SM. Cardiovascular stem cells in regenerative medicine: ready for prime time? Drug Discov Today Ther Strateg. 2008;5:201-207.
43. Okita K, Nakagawa M, Hyenjong H, Ichisaka T, Yamanaka S. Generation of mouse induced pluripotent stem cells without viral vectors. Science. 2008;7;322:949-953.
44. Stadtfeld M., Nagaya M, Utikal J, Weir G, Hochedlinger K. Induced pluripotent stem cells generated without viral integration. Science. 2008;322:945-949.
45. Ellison GM, Torella D, Karakikes I, Nadal-Ginard B. Myo-cyte death and renewal: modern concepts of cardiac cellular homeostasis. Nat Clin Pract Cardiovasc. 2007;4:S52-S59.
46. Kajstura J, Urbanek K, Rota M et al. Cardiac stem cells and myocardial disease. J Mol Cell Cardiol. 2008;45:505-513.
47. Beltrami A P, Barlucchi L, Torella D et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell. 2003;114:763-776.
48. Messina E, De Angelis L, Frati G et al. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res. 2004;95:911-921.
49. Barile L, Messina E, Giacomello A, Marban E. Endogenous cardiac stem cells. Prog Cardiovasc Dis. 2007;50:31-48.
50. Bearzi C, Rota M, Hosoda T et al. Human cardiac stem cells. Proc Natl Acad Sci USA. 2007;104:14068-14073.
51. Linke A, ller PM, Nurzynska D et al. Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function. Proc Natl Acad Sci USA. 2005;102:8966-8971.
52. Oh H, Bradfute SB, Gallardo TD et al. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci USA. 2003;100: 12313-12318.
53. Bergmann O, Bhardwaj RD, Bernard S et al. Evidence for cardiomyocyte renewal in humans Science. 2009:324:98-102.
54. Urbanek K, Torella D, Sheikh F et al. Myocardial regeneration by activation of multipotent cardiac stem cells in is-chemic heart failure. Proc Natl Acad Sci USA. 2005;102: 8692-8697.
55. Goodell MA, Brose K, Paradis G, Conner AS, Mulligan RC. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med 1996;183: 1797-1806.
56. Challen GA, Little MH. A side order of stem cells: the SP phenotype. Stem Cells. 2006;24:3-12.
57. Hierlihy AM, Seale P, Lobe CG et al. The post-natal heart contains a myocardial stem cell population. FEBS Lett. 2002;530:239-243.
58. Martin CM, Meeson A P, Robertson SM et al. Persistent expression of the ATP-binding cassette transporter, Abcg2, identifies cardiac SP cells in the developing and adult heart. Dev Biol. 2004;265:262-275.
59. + cardiac side population cells exhibit functional cardiomyogenic differentiation. Circ Res. 2005;97:52-61.
60. Oyama T, Nagai T, Wada H et al. Cardiac side population cells have a potential to migrate and differentiate into cardiomyo-cytes in vitro and in vivo. J Cell Biol. 2007;176:329-341.
61. Mouquet F, Pfister O, Jain M et al. Restoration of cardiac progenitor cells after myocardial infarction by self-proliferation and selective homing of bone marrow-derived stem cells. Circ Res. 2005;97:1090-1092.
62. Tomita Y, Matsumura K, Wakamatsu Y et al. Cardiac neural crest cells contribute to the dormant multipotent stem cell in the mammalian heart. J. Cell Biol. 2005;170:1135-1146.
63. Beltrami A P, Barlucchi L, Torella D et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell. 2003;114:763-776.
64. Rota M, Padin-Iruegas ME, Misao Y et al. Local activation or implantation of cardiac progenitor cells rescues scarred infarcted myocardium improving cardiac function. Circ Res. 2008;103:107-116.
65. Li M, Naqvi N, Yahiro E et al. c-kit is required for cardiomyo-cyte terminal differentiation. Circ Res. 2008;102:677-685.
66. Tallini YN, Greenea KS, Cravena M et al. c-kit expression identifies cardiovascular precursors in the neonatal heart. Proc Natl Acad Sci USA. 2009;106:1808-1013.
67. + cardiac stem cells derived from adult rat hearts. Stem Cells Dev. 2010;19:105-116.
68. Matsuura K, Nagai T, Nishigaki N et al. Adult cardiac Sca-1--positive cells differentiate into beating cardiomyocytes. J Biol Chem. 2004;279:11384-11391.
69. - cardiac progenitor cell population in post infarction left ventricular remodeling. Stem Cells. 2006;24:1779-1788.
70. Tateishi K, Ashihara E, Takehara N et al. Clonally amplified cardiac stem cells are regulated by Sca-1 signaling for efficient cardiovascular regeneration. J Cell Sci. 2007;120:1791-1800.
71. - cardiac side population cells in a murine myocardial ischemic model. Int J Cardiol. 2010; 138:40-49.
72. + cardio-blasts enter fully differentiated cardiomyocyte lineages. Nature. 2005;433:647-653.
73. Wu SM, Chien KR, Mummery C. Origins and fates of cardiovascular progenitor cells. Cell. 2008;132:537-543.
74. + progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell. 2006;127:1151-1165.
75. + cardiovascular progenitors. FASEB J. 2010;24:700-711.
76. Zhou B, Gise A, Ma Q, Rivera-Feliciano J, Pu W T. Nkx2-5--and Isl1-expressing cardiac progenitors contribute to proepi-cardium. Biochem Biophys Res Commun. 2008;375:450-453.
77. Smith RR, Barile L, Cho HC et al. Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation. 2007; 115:896-908.
78. Takehara N, Tsutsumi Y, Tateishi K et al. Controlled delivery of basic fibroblast growth factor promotes human car-diosphere-derived cell engraftment to enhance cardiac repair for chronic myocardial infarction. J Am Coll Cardiol. 2008;52: 185-1865.
79. Slack JM. Origin of stem cells in organogenesis. Science. 2008;322:1498-1501.
80. Pouly J, Bruneval P, Mandet C et al. Cardiac stem cells in the real world. J Thorac Cardiovasc Surg. 2007;135:673-678.
81. Massberg S, Schaerli P, Knezevic-Maramica I et al. Immuno-surveillance by hematopoietic progenitor cells trafficking through blood, lymph, and peripheral tissues. Cell. 2007; 131:994-1008.
82. Winitsky SO, Gopal T V, Hassanzadeh S. et al. Adult murine skeletal muscle contains cells that can differentiate into beating cardiomyocytes in vitro. PLoS Biol 2005;3:e87.
83. Menasché P. Skeletal myoblasts as a therapeutic agent. Prog Cardiovasc Dis. 2007;50:7-17.
84. Murry CE, Wiseman RW, Schwartz SM, Hauschka SD. Skeletal myoblast transplantation for repair of myocardial necrosis. J Clin Invest. 1996;98:2512-2523.
85. Taylor DA, Atkins BZ, Hungspreugs P et al. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med. 1998;4:929-933.
86. He KL, Yi GH, Sherman W et al. Autologous skeletal myo-blast transplantation improved hemodynamics and left ventricular function in chronic heart failure dogs. J Heart Lung Transplant. 2005;24:1940-1949.
87. van den Bos EJ, Thompson RB, Wagner A et al. Functional assessment of myoblast transplantation for cardiac repair with magnetic resonance imaging. Eur J Heart Fail. 2005;7:435-443.
88. Reinecke H, Poppa V, Murry CE. Skeletal muscle stem cells do not transdifferentiate into cardiomyocytes after cardiac grafting. J Mol Cell Cardiol. 2002;34:241-249.
89. Leobon B, Garcin I, Menasche P, Vilquin J T, Audinat E, Char-pak S. Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host. Proc Natl Acad Sci USA. 2003;100:7808-7811.
90. Siminiak T, Kalawski R, Fiszer D et al. Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury: phase I clinical study with 12 months of follow-up. Am Heart J. 2004;148:531-537.
91. Menasché P, Alfieri O, Janssens S et al. The myoblast autolo-gous grafting in ischemic cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation. 2008;117:1189-1200.
92. Payne TR, Oshima H, Okada M et al. Relationship between vascular endothelial growth factor, angiogenesis, and cardiac repair after muscle stem cell transplantation into ischemic hearts. JACC. 2007;50:1677-1684.
93. Roell W, Lewalter T, Sasse P et al. Engraftment of connexin 43- expressing cells prevents post-infarct arrhythmia. Nature. 2007;450:819-824.
94. Young P P, Vaughan DE, Hatzopoulos AK. Biologic properties of endothelial progenitor cells and their potential for cell therapy. Prog Cardiovasc Dis. 2007;49:421-429.
95. Badorff C, Brandes R P, Popp R et al. Trans differentiation of blood derived human adult endothelial progenitor cells into functionally active cardiomyocytes. Circulation. 2003;107: 1024-1032.
96. Koyanagi M, Bushoven P, Iwasaki M, Urbich C, Zeiher AM, Dimmeler S. Notch signaling contributes to the expression of cardiac markers in human circulating progenitor cells. Circ Res. 2007;101:1139-1145.
97. Flaherty M P, Abdel-Latif A, Li Q et al. Noncanonical Wnt11 signaling is sufficient to induce cardiomyogenic differentiation in unfractionated bone marrow mononuclear cells. Circulation. 2008;117:2241-2252.
98. Asahara T, Murohara T, Sullivan A et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997;275:964-967.
99. Orlic D, Kajstura J, Chimenti S et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001;410:701-705.
100. Orlic D, Kajstura J, Chimenti S et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci USA. 2001;98:10344-10349.
101. Kajstura J, Rota M, Whang B et al. Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion. Circ Res. 2005;96:127-137.
102. Rota M, Kajstura J, Hosoda T et al. Bone marrow cells adopt the cardiomyogenic fate in vivo. Proc Natl Acad Sci USA. 2007; 104:17783-17788.
103. + hematopoietic stem cells with anti- CD45 x anti-myosin light chain bispecific antibody preserves cardiac function in myocardial infarction. J Appl Physiol. 2008;104:1793-1800.
104. Shintani S, Murohara T, Ikeda H et al. Mobilization of endot-helial progenitor cells in patients with acute myocardial infarction. Circulation. 2001;103:2776-2779.
105. Wojakowski W, Tendera M, Michalowska A et al. Mobilization of CD34/CXCR4ţ, CD34/CD117ţ, c-metţ stem cells, and mononuclear cells expressing early cardiac, muscle, and endothelial markers into peripheral blood in patients with acute myocardial infarction. Circulation. 2004;110:3213-3220.
106. Murry CE, Soonpaa MH, Reinecke H et al. Haematopoietic stem cells do not trans differentiate into cardiac myocytes in myocardial infarcts. Nature. 2004;428:664-668.
107. Ince H, Petzsch M, Kleine HD et al. Prevention of left ventricular remodeling with G-CSF after acute myocardial infarction: final one-year results of the FIRSTLINE-AMI trial (front-integrated revascularization and stem cell liberation in evolving acute myocardial infarction by granulocyte colony-stimulating factor). Circulation. 2005;112(9 Suppl):I73-80.
108. Leone AM, Rutella S, Bonanno G et al. Endogenous G-CSF and CD34ţ cell mobilization after acute myocardial infarction. Int J Cardiol. 2005;111:202-208.
109. Harada M, Qin Y, Takano H et al. G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes. Nat Med. 2005;11:305-311.
110. Beohar N, Flaherty JD, Davidson CJ et al. Granulocyte-colony stimulating factor administration after myocardial infarction in a porcine ischemia-reperfusion model: functional and pathological effects of dose timing. Catheter Cardiovasc In-terv. 2007;69:257-266.
111. Rehman J, Li J, Orschell CM, March KL. Peripheral blood éndothelial progenitor cellś are derived from monocyte/mac-rophages and secrete angiogenic growth factors. Circulation. 2003;107:1164-1169.
112. Kinnaird T, Stabile E, Burnett MS, Epstein SE. Bone-marrow derived cells for enhancing collateral development: mechanisms, animal data, and initial clinical experiences. Circ Res. 2004;95:354-363.
113. Mathieu M, Bartunek J, Oumeiri E et al. Cell therapy with autologous bone marrow mononuclear stem cells is associated with superior cardiac recovery compared with use of non modified mesenchymal stem cells in a canine model of chronic myocardial infarction. J Thorac Cardiovasc Surg. 2009;138:646-653.
114. Pittenger MF, Martin BJ. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res. 2004;95:9-20.
115. Tomita S, Li RK, Weisel RD et al. Autologous transplantation of bone marrow cells improves damaged heart function. Circulation. 1999;100(suppl):II247-II256.
116. Jackson KA, Majka SM, Wang H et al. Regeneration of is- chemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest. 2001;107:1395-1402.
117. Shiota M, Heike T, Haruyama M et al. Isolation and characterization of bone marrow-derived mesenchymal progenitor cells with myogenic and neuronal properties. Exp Cell Res. 2007;313:1008-1023.
118. Gnecchi M, Zhang Z, Ni A, Dzau VJ. Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res. 2008; 103:1204-1219.
119. Aggarwal S, Pittenger M F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood. 2005; 105:1815-1822.
120. Amado LC, Saliaris A P, Schuleri KH et al. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci USA. 2005; 102:11474-11479.
121. Zhang M, Mal N, Kiedrowski M et al. SDF-1 expression by mes-enchymal stem cells results in trophic support of cardiac myo-cytes after myocardial infarction. FASEB J. 2007;21:3197-3207.
122. Haider HK, Jiang S, Idris NM, Ashraf M. IGF-1-overexpress-ing mesenchymal stem cells accelerate bone marrow stem cell mobilization via paracrine activation of SDF-1alpha/CXCR4 signaling to promote myocardial repair. Circ Res. 2008; 103:1300-1308.
123. Zeng B, Chen H, Zhu C, Ren X, Lin G, Cao F. Effects of combined mesenchymal stem cells and heme oxygenase-1 therapy on cardiac performance. Eur J Cardio-thorac. 2008;34:850-856.
124. Alfaro M P, Pagni M, Vincent A et al. The Wnt modulator sFRP2 enhances mesenchymal stem cell engraftment, granulation tissue formation and myocardial repair. Proc Natl Acad Sci USA. 2008;105:18366-18371.
125. Toma C, Pittenger M F, Cahill KS, Byrne BJ, Kessler PD. Human mesenchymal stem cells differentiate to a cardiomyocyte pheno-type in the adult murine heart. Circulation. 2002;105:93-98.
126. Schuleri KH, Amado LC, Boyle AJ et al. Early improvement in cardiac tissue perfusion due to mesenchymal stem cells. Am J Physiol Heart Circ Physiol. 2008;294:2002-2011.
127. Quevedo HC, Hatzistergosa KE, Oskoueia BN et al. Alloge-neic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity. PNAS 2009;106:14022-14027.
128. Potapova IA, Doronin S V, Kelly DJ et al. Enhanced recovery of mechanical function in the canine heart by seeding an extracellular matrix patch with mesenchymal stem cells committed to a cardiac lineage. Am J Physiol Heart Circ Physiol. 2008; 259:2257-2263.
129. Breitbach M, Bostani T, Roell W et al. Potential risks of bone marrow cell transplantation into infarcted hearts. Blood. 2007;110:1362-1369.
130. Yoon YS, Park JS, Tkebuchava T, Luedeman C, Losordo DW. Unexpected severe calcification after transplantation of bone marrow cells in acute myocardial infarction. Circulation. 2004;109:3154-3157.
131. Jezierska-Woźniak K, Nosarzewska D, Tutas A, Mikołajczyk A, Okliński M, Jurkowski MK. Use of adipose tissue as a source of mesenchymal stem cells. Postepy Hig Med Dosw. 2010; 64:326-32.
132. Robdell M. Metabolism of isolated fat cells. Effect of hormone on fat metabolism and lipolysis. J Biol Chem. 1964;223:375-380.
133. Robdell M, Jones AB. Metabolism of isolated fat cells. The similar inhibitory action of phospholipase c (clostridium per-fringens alpha toxin) and of insulin on lipolysis stimulated by lipolytic hormones and theophylline. J Biol Chem. 1966; 241:140-142.
134. Rangappa S, Entwistle J W, Wechsler AS, Kresh JY. Cardio-myocyte - mediated contact programa human mesenchymal stem cells to express cardiogenic phenotype. J Thorac Cardio-vasc Surg. 2003;126:124-132.
135. Psaltis PJ, Zannettino AC, Worthley SG, Gronthos S. Concise review: mesenchymal stromal cells: potential for cardiovascular repair. Stem Cells. 2008;26:2201-2210.
136. Planat-Bénard V, Menard C, André M et al. Spontaneous car-diomyocyte differentiation from adipose tissue stromal cells. Circ Res. 2004;94:223-229.
137. Gaustad K.G, Boquest AC, Anderson BE, Gerdes AM, Col-las P. Differentiation of human adipose tissue stem cells using extracts of rat cardiomyocytes. Biochem Biophys Res Commun. 2004;314:420-427.
138. Gimble JM, Katz AJ, Bunnell BA. Adipose-derived stem cells for regenerative medicine. Circ Res. 2007;11;100:1249-1260.
139. Yamada Y, Wang XD, Yokoyama S, Fukuda N, Takakura N. Cardiac progenitor cells in brown adipose tissue repaired damaged myocardium. Biochem Biophys Res Commun. 2006; 342:662-670.
140. Yamada Y, Yokoyama S, Wang XD, Fukuda N, Takakura N. Cardiac stem cells in brown adipose tissue express CD133 and induce bone marrow nonfematopoetic cells to differentiate into cardiomyocytes. Stem Cells. 2007;25:1326-1333.
141. Song YH, Gehmert S, Sadat P et al. VEGF is critical for spontaneous differentiation of stem cells into cardiomyocytes. Bio-chem Biophys Res Commun. 2007;354:999-1003.
142. Nakagami H, Morishita R, Maeda K, Kikuchi Y, Ogihara T, Kaneda Y. Adipose tissue-derived stromal cells as a novel option for regenerative cell therapy. J Atheroscler Thromb. 2006;13:77-81.
143. Nakagami H, Morishita R, Maeda K et al. Novel autologous cell therapy in ischemic limb disease through growth factor secretion by cultured adipose tissue-derived stromal cells. Ar-terioscler Thromb Vasc Biol. 2005;25:2542-2547.
144. Rehman J, Traktuev D, Li J et al. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation. 2004;109:1292-1298.
145. Cao Y, Sun Z, Liao L et al. Human adipose tissue-derived stem cells differentiate into endothelial cells in vitro and improve postnatal neovascularization in vivo. Biochem Biophys Res Commun. 2005;332:370-379.
146. Bai X, Yan Y, Song YH et al. Both cultured and freshly isolated adipose tissue-derived stem cells enhance cardiac function after acute myocardial infarction. Eur Heart J. 2009;31:489-501.
147. Jumabay M, Matsumoto T, Yokoyama S et al. Dedifferentiated fat cells convert to cardiomyocyte phenotype and repair infracted cardiac tissue in rats. J Mol Cell Cardiol. 2009;47:565-575.
148. Mazhari R, Hare JM. Advances in cell-based therapy for structural heart disease [Review]. Prog Cardiovasc Dis. 2007;49: 387-395.
149. The Scientist Magazine of the Life Science. Trials of the heart. Available at: http://www.the-scientist.com/supplementary//html/24104/ Accessed May 10, 2010.
150. Tousoulis D, Briasoulis A, Antoniades C, Stefanadi E, Stefa-nadis C. Heart regeneration: what cells to use and how? Curr Opin Pharmacol. 2008;8:211-218.
151. Barbash IM, Chouraqui P, Baron J et al. Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation. 2003;108:863-868.
152. Janssens S, Dubois C, Bogaert J et al. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet. 2006;367:113-121.
153. Perin EC, López J. Methods of stem cell delivery in cardiac diseases. Nat Clin Pract Cardiovasc Med. 2006;3(suppl 1):S110-S113.
154. Gyöngyösi M, Lang I, Dettke M et al. Combined delivery approach of bone marrow mononuclear stem cells early and late after myocardial infarction: the MYSTAR prospective, randomized study. Nat Clin Pract Cardiovasc Med. 2009;6:70-81.
155. Sherman W, Martens T P, Viles-Gonzalez JF, Siminiak T. Catheter-based delivery of cells to the heart. Nat Clin Pract Car-diovasc Med. 2006;3(suppl 1):S57-S64.
156. Hofmann M, Wollert KC, Meyer GP et al. Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation. 2005;111:2198-2202.
157. Teng CJ, Luo J, Chiu RC, Shum-Tim D. Massive mechanical loss of microspheres with direct intramyocardial injection in the beating heart: implications for cellular cardiomyoplasty. J. Thorac. Cardiovasc. Surg. 2006;132:628-632.
158. Bel A, Messas E, Agbulut O, et al. Transplantation of autolo-gous fresh bone marrow into infarcted myocardium: a word of caution. Circulation. 2003;108:II247-II252.
159. Aicher A, Brenner W, Zuhayra M et al. Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling. Circulation. 2003;107:2134-2139.
160. Suzuki K, Murtuza B, Beauchamp JR et al. Dynamics and mediators of acute graft attrition after myoblast transplantation to the heart. FASEB J. 2004;10:1153-1155.
161. Hou D, Youssef EA-S, Brinton TJ et al. Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: implications for current clinical trials. Circulation. 2005;112:I-150.
162. Lyon A, Harding S. The potential of cardiac stem cell therapy for heart failure. Curr Opin Pharmacol. 2007;7:164-170.
163. Singh S, Arora R, Handa K et al. Stem cells improve left ventricular function in acute myocardial infarction. Clin Cardiol. 2009;32:176-180.
164. Chavakis E, Aicher A, Heeschen C et al. Role of beta2- inte-grins for homing and neovascularization capacity of endothe-lial progenitor cells. J Exp Med. 2005;201:63-72.
165. Chavakis E, Urbich C, Dimmeler S. Homing and engraftment of progenitor cells: a prerequisite for cell therapy. J Mol Cell Cardiol. 2008;45:514-522.
166. Brunner S, Huber BC, Fischer R et al. G-CSF treatment after myocardial infarction: impact on bone marrow-derived vs cardiac progenitor cells. Exp Hematol. 2008;36:695-702.
167. Yoon YS, Johnson IA, Park JS, Diaz L, Losordo DW. Therapeutic myocardial angiogenesis with vascular endothelial growth factors. Mol Cell Biochem 2004;264:63-74.
168. Ryzhov S, Solenkova N V, Goldstein AE et al. Adenosine receptor-mediated adhesion of endothelial progenitors to cardiac microvascular endothelial cells. Circ Res. 2008;102: 356-363.
169. Shen J, DiCorleto PE. Adenosine prompts the heart to recruit endothelial progenitors. Circ Res. 2008;102:280-282.
170. Leesar MA, Stoddard M, Ahmed M, Broadbent J, Bolli R. Preconditioning of human myocardium with adenosine during coronary angioplasty. Circulation. 1997;95:2500-2507.
171. Swijnenburg RJ, Govaert JA, van der Bogt KEA et al. Timing of bone marrow cell delivery has minimal effects on cell viability and cardiac recovery after myocardial infarction. Circ Cardiovasc Imaging. 2010;3:77-85.
172. Engler AJ, Sen S, Sweeney HL, Discher DE. Matrix elasticity directs stem cell lineage specification. Cell. 2006;126:677-689.